SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Genes & Development

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/gad.203760.112PMID 23388826PMCID PMC3576513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factor

  2012cited by this paper
• The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

  2012cited by this paper
• Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel

  2011cited by this paper
• TRAF7 Protein Promotes Lys-29-linked Polyubiquitination of IκB Kinase (IKKγ)/NF-κB Essential Modulator (NEMO) and p65/RelA Protein and Represses NF-κB Activation

  2011cited by this paper
• TSPYL5 suppresses p53 levels and function by physical interaction with USP7

  2011cited by this paper
• Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.

  2010cited by this paper
• The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease.

  2010cited by this paper
• The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation

  2009cited by this paper
• Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma

  2009cited by this paper
• Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV‐40 tag rats

  2009cited by this paper
• Gambogic acid induces G0/G1 arrest and apoptosis involving inhibition of SRC-3 and inactivation of Akt pathway in K562 leukemia cells.

  2009cited by this paper
• Involvement of SRC-3 in deguelin-induced apoptosis in Jurkat cells

  2009cited by this paper
• Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

  2009cited by this paper
• Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

  2009influential reference
• Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.

  2008cited by this paper
• Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells.

  2008cited by this paper
• Tumor Necrosis Factor Receptor-Associated Factor 4 Is a Dynamic Tight Junction-Related Shuttle Protein Involved in Epithelium Homeostasis

  2008cited by this paper
• Characterization of immune functions in TRAF4‐deficient mice

  2008cited by this paper
• TRAF4 overexpression is a common characteristic of human carcinomas

  2007influential reference
• Amplified in Breast Cancer 1 in Human Epidermal Growth Factor Receptor–Positive Tumors of Tamoxifen-Treated Breast Cancer Patients

  2007cited by this paper
• TRAF4, the unique family member.

  2007cited by this paper
• SRC-3/AIB1: transcriptional coactivator in oncogenesis

  2006cited by this paper
• Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway

  2006cited by this paper
• Molecular recognition of p53 and MDM2 by USP7/HAUSP

  2006influential reference
• Molecular mechanisms of drug resistance

  2005cited by this paper
• Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.

  2005cited by this paper
• Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.

  2005cited by this paper
• Tumour suppression: Disruption of HAUSP gene stabilizes p53

  2004cited by this paper
• AIB1/SRC-3 Deficiency Affects Insulin-Like Growth Factor I Signaling Pathway and Suppresses v-Ha-ras-induced Breast Cancer Initiation and Progression in Mice

  2004cited by this paper
• Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications

  2004cited by this paper
• Phosphorylation/Cytoplasmic Localization of p21Cip1/WAF1 Is Associated with HER2/neu Overexpression and Provides a Novel Combination Predictor for Poor Prognosis in Breast Cancer Patients

  2004cited by this paper
• High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.

  2004cited by this paper
• A dynamic role of HAUSP in the p53-Mdm2 pathway.

  2004cited by this paper
• Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis

  2003cited by this paper
• TP53 mutations in familial breast cancer: Functional aspects

  2003cited by this paper
• Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

  2003cited by this paper
• Epidermal growth factor receptor: mechanisms of activation and signalling.

  2003cited by this paper
• Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization

  2002cited by this paper
• Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4).

  2002cited by this paper
• Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice

  2002cited by this paper
• BID regulation by p53 contributes to chemosensitivity

  2002cited by this paper
• Tumor necrosis factor receptor-associated factors (TRAFs)

  2001cited by this paper
• A Diverse Family of Proteins Containing Tumor Necrosis Factor Receptor-associated Factor Domains*

  2001cited by this paper
• Altered expression of estrogen receptor coregulators during human breast tumorigenesis.

  2000cited by this paper
• Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.

  1999cited by this paper
• Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

  1999cited by this paper
• Steroid Receptor Coactivator-1 Coactivates Activating Protein-1-mediated Transactivations through Interaction with the c-Jun and c-Fos Subunits*

  1998cited by this paper
• Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis*

  1998cited by this paper
• TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues.

  1998cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cited by this paper
• Presence of a New Conserved Domain in CART1, a Novel Member of the Tumor Necrosis Factor Receptor-associated Protein Family, Which Is Expressed in Breast Carcinoma (*)

  1995cited by this paper
• A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.

  1994cited by this paper
• Access to the Published Version May Require Journal Subscription. Published with Permission From: Springer Epidermal Growth Factor Receptor (egfr) and the Estrogen Receptor Modulator Amplified in Breast Cancer (aib1) for Predicting Clinical Outcome after Adjuvant Tamoxifen in Breast Cancer

  year unknowncited by this paper

• Recent advances in small molecule inhibitors of deubiquitinating enzymes.

  2025cites this paper
• Mechanism Study of Bufalin Reversal of Drug Resistance by Inhibiting Hypoxic Colon Cancer Cell-Induced Polarization of M2 Macrophages

  2025cites this paper
• Dysregulation of deubiquitination in breast cancer.

  2024cites this paper
• Friend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases.

  2024cites this paper
• USP7 - a crucial regulator of cancer hallmarks.

  2023cites this paper
• SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway

  2023influential citation
• AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer

  2023cites this paper
• USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis

  2023cites this paper
• Current and future directions of USP7 interactome in cancer study.

  2023cites this paper
• TRAF4 maintains deubiquitination of Caveolin-1 to drive glioblastoma stemness and Temozolomide resistance.

  2022cites this paper
• The Research Progress in Physiological and Pathological Functions of TRAF4

  2022cites this paper
• Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myeloma

  2021cites this paper
• Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.

  2021cites this paper
• SRC-3, a Steroid Receptor Coactivator: Implication in Cancer

  2021cites this paper
• AWARD NUMBER: W81XWH-15-1-0536 TITLE: TRAF4 and Castration-Resistant Prostate Cancer PRINCIPAL INVESTIGATOR: Ping Yi CONTRACTING ORGANIZATION: Baylor College of Medicine

  2020cites this paper
• High expression of TRAF4 predicts poor prognosis in tamoxifen-treated breast cancer and promotes tamoxifen resistance

  2020cites this paper
• Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer.

  2020cites this paper
• Roles of TRAFs in Ischemia-Reperfusion Injury

  2020cites this paper
• TRAF4 promotes endometrial cancer cell growth and migration by activation of PI3K/AKT/Oct4 signaling.

  2019cites this paper
• USP7-Dependent Regulation of TRAF Activation and Signaling by a Viral Interferon Regulatory Factor Homologue

  2019cites this paper
• SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.

  2019cites this paper
• USP7: Structure, substrate specificity, and inhibition.

  2019cites this paper
• TRAF4 promotes fibroblast proliferation in keloids by destabilizing p53 via interacting with the deubiquitinase USP10.

  2019influential citation
• Inhibition of proliferation and migration of tumor cells through lipoic acid-modified oligoethylenimine-mediated p53 gene delivery

  2019cites this paper
• Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells

  2018cites this paper
• USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells

  2018cites this paper
• A novel isolation method for cancer prognostic factors via the p53 pathway by a combination of in vitro and in silico analyses

  2018cites this paper
• Genetic Alterations of TRAF Proteins in Human Cancers

  2018cites this paper
• TRAF4‐mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis

  2018cites this paper
• Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer

  2017cites this paper
• Structural Insight into the Mechanisms of Activation and Substrate Specificity of Human Deubiquitinating Enzyme USP7

  2016cites this paper
• Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation.

  2016cites this paper
• Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors.

  2016cites this paper
• TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.

  2015cites this paper
• Original Article TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway

  2015cites this paper
• Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer

  2015influential citation
• The phosphoinositide-binding protein TRAF4 modulates tight junction stability and migration of cancer cells

  2014cites this paper
• [TRAF4, a multifaceted protein involved in carcinoma progression].

  2014cites this paper
• TRAF4 Enhances Osteosarcoma Cell Proliferation and Invasion by Akt Signaling Pathway

  2014cites this paper
• Impaired hematopoiesis and delayed thrombopoietic recovery following sublethal irradiation in SRC-3 knockout mice

  2014cites this paper
• TRAF4 promotes tumorigenesis of breast cancer through activation of Akt.

  2014cites this paper
• Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes.

  2014cites this paper
• Nuclear receptor coactivators: master regulators of human health and disease.

  2014cites this paper
• Tumor necrosis factor Receptor-Associated Factor 4 (TRAF4) est une nouvelle protéine interagissant avec les phosphoinositides, impliquée dans la polarité et la migration cellulaire

  2013influential citation
• Steroid receptor coactivator-3 promotes bladder cancer through upregulation of CXCR4.

  2013cites this paper
• Increased radiosensitivity and radiation-induced apoptosis in SRC-3 knockout mice

  2013cites this paper
• TRAF4 Is a Novel Phosphoinositide-Binding Protein Modulating Tight Junctions and Favoring Cell Migration

  2013influential citation
• NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells

  2013cites this paper